Read + Share
Amedeo Smart
Independent Medical Education
Ferreira JP, Fitchett D, Ofstad AP, Kraus BJ, et al. Empagliflozin for Patients with Presumed Resistant Hypertension: a Post Hoc Analysis of the EMPA-REG OUTCOME Trial. Am J Hypertens 2020 May 5. pii: 5830772. doi: 10.1093.PMID: 32369546
Email
LinkedIn
Facebook
Twitter
Privacy Policy